5
项与 177Lu-CTR-FAPI 相关的临床试验A Single-Center, Single-Arm, Open-Label Clinical Study of 177Lu-CTR-FAPI Injection in the Treatment of Patients With Advanced, Metastatic Solid Tumors
This is a single-center, single-arm, open-label clinical study of 177Lu-CTR-FAPI injection in the treatment of patients with advanced, metastatic solid tumors i.e. pancreatic cancer, to assess safety, radio-dosimetry, and efficacy per RESIST 1.1.
/ Not yet recruitingN/AIIT A Single-Center, Single-Arm, Open-Label Clinical Study of 177Lu-CTR-FAPI Injection in the Treatment of Patients with Advanced, Metastatic Solid Tumors
/ Not yet recruitingN/AIIT Therapeutic Study of 177Lu-CTR-FAPI-targeted Nuclear Drugs in Advanced Metastatic Digestive Malignancies
This was a single-centre, single-arm, non-blinded, prospective study using 20 patients with advanced metastatic GI malignancies recruited to treat patients with advanced metastatic GI malignancies with 177Lu-CTR-FAPI to assess the safety of 177Lu-CTR-FAPI in advanced metastatic GI malignancies; this included radiation therapy dosimetry and initial treatment Determination of Effectiveness
100 项与 177Lu-CTR-FAPI 相关的临床结果
100 项与 177Lu-CTR-FAPI 相关的转化医学
100 项与 177Lu-CTR-FAPI 相关的专利(医药)
100 项与 177Lu-CTR-FAPI 相关的药物交易